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RESEARCH PROTOCOL  
A retrospective audit of morbidity and mortality associated with open 




Open AAA repair is a major, high risk surgery and is associated with significant 
morbidity and mortality. Current literature quotes an overall mortality of ruptured 
AAA at 85-90%, including those who do not reach the operating theatre. Mortality of 
elective AAA repairs is 4-8%1.  
Many patients presenting with abdominal aortic aneurysms are elderly and have 
pre-existing medical conditions, therefore putting them at high risk for numerous 
post-operative complications. 
Causes of post-operative morbidity include: renal failure, pulmonary and cardiac 
complications, as well as paralysis. Such post-operative complications lead to 
potentially increased ICU and hospital stays. 
 
JUSTIFICATION FOR RESEARCH 
An audit into the morbidity and mortality at Groote Schuur has not yet been formally 
performed. Such a retrospective audit will be useful in establishing where this 
hospital stands in terms of mortality, as compared with published data from other 
centres. 
In terms of morbidity, this research will chiefly focus on the development of renal 
dysfunction following AAA repair. It is known that renal dysfunction is one of the five 
preoperative risk factors that predict mortality following ruptured AAA repair. It is the 
most easily assessed risk factor for a retrospective audit.  
Other risk factors include: age >76 years, haemoglobin less than 9 g/dL, loss of 
consciousness and ECG evidence of ischaemia2. If renal dysfunction results in 
failure (defined as a creatinine >335 µmol/L, according to the RIFLE criteria), and 
necessitates renal replacement therapy, mortality can then be as high as 50%, 
independent of other risk factors3. 
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By conducting an audit of renal failure post AAA repair at Groote Schuur, we will 




Primary outcome: perioperative mortality associated with open repair of abdominal 
aortic aneurysms. 
Secondary outcomes: incidence of acute kidney injury, need for renal replacement 
therapy and duration of hospital and ICU stays.  
 
STUDY DESIGN 
A retrospective file audit of emergency and elective open abdominal aortic 
aneurysm repairs will be carried out.  
The researcher will review folders of patients who have had repairs in the past five 
years, or a cohort of 100 patients. Each folder number will be assigned a study 
number in the database, to ensure anonymity of subjects.  
 
SUBJECT SELECTION 
Study subjects selected will be those having undergone open AAA repair in the five-
year period between 01 July 2009 and 30 June 2014. (The study period was 
amended to October 2006 until 31 December 2014, in order to reach the target of 
100 patients; the amendment was approved by the Human Research Ethics 
Committee on 02 December 2016). 
Folder numbers will be obtained from theatre operation notes, which are kept at the 
Groote Schuur Hospital main theatre complex. The folders will be obtained, with due 
permission, from the Medical Records Department. Pertinent information will be 
extracted, taking care not to reveal subject identities.  
 
EXCLUSION CRITERIA 
 Patients who have undergone endovascular aneurysm repair (EVAR) 
 Patients with thoraco-abdominal aortic aneurysm repairs 
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 Patients who did not survive operation of AAA; that is, those who demised 
during the initial operation 
 Patients for whom a complete set of data is not available 
 
MEASUREMENT 
Data will be collected using a specially designed case record folder (see Appendix). 
The data collected will be captured electronically on a Microsoft Excel™ spread 
sheet. 
 
LIST OF VARIABLES 
 Gender 
 Date of birth 
 Age at operation 
 Comorbidities—any known comorbidities, which will be indicated in clinical 
notes 
 Date of operation 
 Elective/Emergency 
 Type of aneurysm (Saccular/Fusiform)—description in operation notes 
 Position of aneurysm—indicated in operation and/or clinical notes; commonly 
described as infrarenal, juxtarenal and suprarenal 
 Position of aortic cross-clamp (supracoeliac/suprarenal/infrarenal) 
 Duration of aortic cross-clamp 
 Date of admission to ICU 
 Date of ICU discharge  
 Total length of ICU stay 
 Days ventilated 
 Date of death 
 Cause of death 
 Date of hospital discharge 
 Renal replacement therapy (RRT) commenced (Yes/No) 
 Creatinine on admission to hospital— information on blood results will be 
obtained either from the patient file, or our National Health Laboratory 
Services database, using folder numbers. 
 Creatinine on commencement of RRT 
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 Creatinine on date of death, or on discharge from hospital 
 Dialysis dependent at hospital discharge (Yes/No) 
 
QUALITY CONTROL 
The data will be collected solely by the primary investigator, to ensure that all 
necessary variables are collected. 
 
PILOT STUDY 
Data will initially be collected for the year from 01 July 2013 to 30 June 2014. It is 
estimated that this will hopefully yield at least 20 study subjects and their folders. 
Should this target not be met (i.e. 20 study subjects within the selected year), then 
data will be collected retrospectively for a prolonged period, in order to gain an 
overall study population of 100.  
 
ANALYSIS 
Data analysis will be performed using Stata 13, and will utilise the Mann-Whitney 
and Fisher’s Exact tests.  
 
ETHICS AND COMMUNICATION 
1. ETHICS 
As this is a retrospective file audit, there is no need for consent. Subjects will not be 
contacted in any way, and patients’ identities will not be revealed. Ethical approval 
will be obtained from the University of Cape Town’s Human Research Ethics 
Committee. 
2. REPORTING AND IMPLEMENTATION 
The outcome of this research will especially be communicated to the Department of 
Vascular Surgery, as well as the Department of Critical Care. The results of this 






December 2014 to June 2015 Ethics approval; data collection; 
commencement of literature review 
June 2015 to May 2016 FCA Part 2 examination preparation 
May 2016 to November 2016 Data analysis, in conjunction with statistician; 
write-up of results 
November 2016 Submission of dissertation 
 
BUDGET AND OTHER LOGISTICS 
There is no need for external funding. Costs will be borne by the primary 
investigator.  
Folder numbers of subjects having undergone open repair of AAA, will be obtained 
from theatre operating notes. Files will be drawn from Medical Records Department, 
in order to collect pertinent information. 
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MORBIDITY AND MORTALITY ASSOCIATED WITH OPEN ABDOMINAL 
AORTIC ANEURYSM REPAIRS 
 
1. OBJECTIVES OF LITERATURE REVIEW 
The purpose of this literature review is to provide a brief overview on the topic of 
abdominal aortic aneurysms (AAAs) and the surgical repair thereof.  The researcher 
will then examine the mortality and morbidity associated with open AAA repairs at 
different centres, paying special attention to acute kidney injury, and its outcomes 
following renal replacement therapy. Lastly, the researcher will review the costs 
associated with renal replacement therapy. 
 
2. LITERATURE SEARCH STRATEGY 
The researcher conducted PubMED and Google Scholar searches through the 
University of Cape Town’s Faculty of Health Sciences’ online library. 
 
3. QUALITY CRITERIA 
A PubMed MeSH search was conducted using the following keywords: Aortic 
aneurysm, abdominal AND acute kidney injury AND surgery. Using Google Scholar, 
a literature search to identify articles of relevance to this topic was conducted using 
the following keywords and phrases: abdominal aortic aneurysm repair mortality, 
emergency versus elective abdominal aortic aneurysm open repair mortality, renal 
failure AAA, renal replacement therapy costs, renal replacement therapy outcomes. 
 
4. REVIEW AND CRITICAL APPRAISAL OF LITERATURE 
 
4.1. OVERVIEW OF ABDOMINAL AORTIC ANEURYSM REPAIR 
 
4.1.1. INTRODUCTION 
Abdominal aortic aneurysm (AAA) is defined as a full-thickness widening or 
dilatation of the infradiaphragmatic aorta to a diameter of greater than 3.0 cm. The 
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normal diameter of the abdominal aorta in adults ranges from 2.0 to 3.0 cm. The 
underlying mechanism of the development of aneurysms is still unclear. However, it 
is pathologically marked by the degradation of the elastic media of the aorta. In most 
cases, non-specific degeneration and atheromatous changes of the aorta contribute 
to this degradation. Others aneurysms can be attributed to chronic infection such as 
tuberculosis, acute infection, trauma, inflammatory disorders and connective tissue 
disorders1. 
Abdominal aortic aneurysms are categorised anatomically according to aetiology, 
morphology and position. The morphology of an aneurysm can be described either 
as fusiform or as saccular, and is linked to its aetiology. ‘Fusiform’ implies that the 
entire circumference of the aorta is involved. Fusiform aneurysms tend to be from 
non-specific, degenerative causes. ‘Saccular’ implies that only a part of the 
circumference is involved. Saccular aneurysms mostly have other, usually infective, 
aetiologies. The majority of AAAs are fusiform27.  
The position of the aneurysm is described in relation to the renal arteries. 
Suprarenal aneurysms involve that portion of the aorta that is above the renal ostia. 
Juxtarenal aneurysms are situated below the renal ostia, where there is no segment 
of non-aneurysmal aorta between the renal arteries and the aneurysm. Infrarenal 
aneurysms are situated below the level of the renal arteries, where there is a 
segment of nonaneurysmal aorta between the renal arteries and the beginning of 
the aneurysmal dilatation27. 
 
4.1.2 INCIDENCE OF AAA 
AAAs affect more males than females, being more common in those older than 65 
years of age. Studies place the prevalence of AAAs in males at 1.3-8.9%, and at 
1.0-2.2% in females1. The greatest contributor to aneurysm formation and 
progression is tobacco smoking2. Other factors that have been identified include 
hypertension, hyperlipidaemia, chronic obstructive pulmonary disease (COPD) and 
a positive family history of AAA1. Patients presenting with AAAs are likely to have 
one or more comorbidities. 
Aneurysmal dilatation of the aorta may be asymptomatic, being diagnosed on 
routine abdominal examination. Some patients do become symptomatic, 
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experiencing back, abdominal and/or flank pain, tenderness over the aneurysm, or 
the non-specific systemic symptoms of malaise and fever27. 
Elective surgical repair of AAAs is usually carried out in the asymptomatic patient 
with an aneurysm diameter exceeding 5.5cm, or in the symptomatic patient with an 
aneurysm of any diameter. Current guidelines state that operating in an 
asymptomatic patient with an AAA with a diameter of less than 5.5cm does not 
confer any benefit in terms of post-operative mortality or morbidity3.  
Ruptured AAAs require emergency repair. Rupture of the aorta occurs when arterial 
wall thickness deteriorates to such an extent as to result in extravasation of blood. 
Among the patients who present with ruptured AAAs, and who undergo emergency 
repair, the mortality rate is as high as 85-90%1.  
 
4.1.3 SURGICAL REPAIR OF AAA 
The mainstay of surgical repair is via the open route, through either transperitoneal 
(midline or transverse) or retroperitoneal approaches27.  
Endovascular repair of abdominal aortic aneurysms (EVAR) has been gaining 
popularity since it was introduced in the early 1990s; currently it is reserved for 
those patients deemed unfit for open repair of the AAA4.   
EVAR is significantly less invasive, and better tolerated, than open AAA, as access 
to the aneurysm is obtained through groin dissection and cannulation. EVAR does 
not involve aortic cross-clamping, and so avoids the negative sequelae thereof. The 
aneurysm must, however, be anatomically suitable for EVAR; that is, there must be 
sufficient normal aorta above and below the aneurysm to adequately seat the graft.5  
 
4.1.4 PHYSIOLOGY OF AORTIC CROSS-CLAMPING 
Open surgical repair of AAAs, by whichever approach, involves exposure of the 
aorta, aortic cross-clamping, and placement of a graft. This is followed by aortic 
unclamping and reperfusion of the distal structures.6 
The anatomical level of the aneurysm will determine the level of aortic cross-clamp 
placement. The physiological sequelae of cross-clamping depend on the level of 
cross-clamp placement, being more exaggerated with more proximal placement.  
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Cross-clamp placement results in increased systemic vascular resistance and 
arterial pressure, as well as an increased myocardial afterload. The increased 
afterload results in enhanced myocardial contractility and oxygen demand7. There is 
interruption of the blood supply to the lower body. Perfusion of structures distal to 
the clamp thus becomes dependent on collateral blood supply. During cross-
clamping, organs with blood supply originating from the distal aorta are vulnerable to 
ischaemia and subsequent injury. Regardless of the level of the clamp, renal 
perfusion is affected; in fact, infrarenal clamps are said to decrease renal blood flow 
by up to 60%6. 
Unclamping of the aorta conversely results in sudden decrease in afterload, which 
may necessitate attenuation via the administration of fluids and/or vasopressors. 
Reperfusion of ischaemic tissue leads to the release of vasoactive substances, 
which suppress myocardial tissue and further exacerbate hypotension7. The 
decrease in afterload causes a decrease in coronary blood flow, which is likely to 
result in myocardial ischaemia if left untreated.  
 
4.2 POST-OPERATIVE MORBIDITY AND MORTALITY 
Hertzer et al8 from the Cleveland Clinic published data collected from 1989 to 1998. 
In that period, there were 1 135 patients that underwent open repairs of infrarenal 
AAAs. The majority of those patients were male (985 versus 150 female); the 
median age was 70 years. They reported a 30-day mortality of 1.2%.  Mortality was 
due to cardiac causes in three patients, pulmonary complications in three cases and 
multiorgan failure in four patients. Four (4) deaths were attributed to a category 
termed ‘other causes’. 
Six patients (0.5%) required dialysis postoperatively, excluding patients who were 
on dialysis prior to surgery. Complication rates tended to be increased in those 
patients with COPD, prior congestive cardiac failure, pre-existing renal insufficiency, 
pre-operative dialysis, and increased age. 
In the UK Small Aneurysm Trial3, a total of 1 090 patients were randomised to two 
groups: early (aortic diameter 4.0-5.5cm) versus late (aortic diameter >5.5cm) open 
repair of AAAs. Five hundred and sixty-three (563) patients were assigned to the 
former, early group, and 527 were assigned to the latter, surveillance group. Five 
hundred and seventeen (517) of the early group ultimately underwent elective 
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repair, and a further two patients underwent emergency repair for aneurysm rupture. 
In the latter group, 321 patients eventually underwent elective repair. Patients in the 
two groups were comparable in terms of age and gender, and were followed up for a 
period of five years. In the early open surgery group, the 30-day mortality was 5.8%. 
Certain risk factors were associated with a higher risk of death. These included: 
increased age, larger aortic diameter, poorer lung function, and lower ankle/brachial 
index (a marker of severe peripheral vascular disease). In the surveillance group, 
321 out of 527 underwent elective repair. One hundred and fifty (150) of these 
patients died during the trial. This group had 17 deaths from ruptured AAAs 
(compared with six deaths from the same aetiology in the early surgery group). 
The 820 patients from the UK Small Trial who underwent elective open repair of 
their AAAs were further analysed, in order to ascertain identifiable risk factors for 
post-operative death. The 30-day mortality was 5.6%. The leading cause for death 
was cardiac, followed by pulmonary and renal causes of death.  
Menard et al9 followed a series of 572 patients undergoing surgical repair of 
unruptured infrarenal AAAs between 1990 and 2000. They separated these patients 
into low-risk and high-risk groups. Patients belonging to the high-risk groups were 
those with higher American Society of Anaesthesiologists (ASA) grading, age 
greater than 80 years, pre-operative serum creatinine greater than 3.0 mg/dL (265 
µmol/L), pulmonary insufficiency (domiciliary oxygen use, FEV1 <20% of predicted 
or FEF25-75 <20% predicted), hepatic failure and cardiac dysfunction (LVEF <20%, 
congestive heart failure, unstable angina, coronary artery disease not amenable to 
grafting, and symptomatic aortic stenosis). One hundred and twenty-eight (128) of 
their patients met one or more criteria for high risk. The other 444 patients were 
classified as low risk. The 30-day mortality in the high risk group was 4.7%, and 
0.0% in the low risk group. This brought the overall 30-day mortality of the cohort of 
572 patients to 1.0%.  The five year survival rate was 46% (high-risk) and 74% (low-
risk). Morbidity was higher in those patients flagged as high-risk, than in their low-
risk counterparts. The major complications were myocardial infarction, renal failure 
and pneumonia, as in the UK Small Trial.  Renal failure occurred in 7% of patients in 
the high risk group, and <1% in the low risk group.  
 
4.3 LONG-TERM OUTCOMES OF OPEN AAA REPAIR 
Long-term outcomes are determined by evaluating beyond five-year mortality.  
Biancari et al10 followed up on 208 subjects who underwent open AAA repair at their 
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centre, in order to evaluate the durability of repair, and reported on five-, 10-, and 15 
year survival rates. The median follow-up period was 8.0 years. The 15-year survival 
rate was 18%. Late mortality was found to be due to myocardial ischaemia, 
cerebrovascular events, pulmonary diseases and cancer. Reoperation was 
necessary in 27 patients. Hertzer and Mascha in Cleveland documented a 15-year 
survival rate of 16%11. 
Long term survival is affected by graft durability. Graft related complications include: 
proximal and distal pseudoaneurysms and graft occlusions, graft-enteric erosion 
fistulae, graft sepsis, atheromatous plaque embolism, anastomotic leak, and colonic 
ischaemia12. 
 
4.4. POST-OPERATIVE RENAL COMPLICATIONS 
Acute kidney injury (AKI), previously known as acute renal failure (ARF), refers to a 
sudden and sustained decrease in renal function13 with subsequent accumulation of 
nitrogenous and non-nitrogenous waste products. It may also be associated with 
hyperkalaemia and metabolic acidosis. 
The incidence of AKI in the general hospital population is reported at about 5%, and 
about 30-50% in intensive care unit patients14. 
AKI is an important negative prognosticator. Existing data of all-cause acute renal 
failure requiring renal replacement therapy in intensive care units, shows a mortality 
rate of between 40 and 80%14,15. The wide range in reported mortality may be 
attributed to the varying definitions of AKI that are used in different studies.  
AKI rarely occurs in isolation, usually occurring in conjunction with failure of one or 
more other systems.  
Korkeila et al14 studied 3447 ICU patients admitted during the period 1992-1993. 
Sixty-nine of these patients (2%) required renal replacement therapy during their 
ICU stay. They showed an in-ICU mortality of 34%, and an in-hospital mortality of 
45%. At six months, the mortality was 55%. This increased to 65% at 5 years. 
AKI complicates the post-operative course of AAA repairs, partly due to pre-existing 
renal disease, and also because of reduced renal blood flow during periods of aortic 
cross clamping. Following the release of aortic cross clamping, reperfusion to the 
kidney may also contribute to AKI.  
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In the Cleveland Clinic’s series of elective open infrarenal AAA repairs8, 1.7% of 
their patients developed acute renal insufficiency post-operatively, defined in their 
study as an increase in serum creatinine of greater than 1 mg/dL (88.4 µmol/L). Six 
(6) patients who were not on dialysis prior to surgery required dialysis. In that series, 
57 patients had a pre-operative serum creatinine of greater than 2 mg/dL  
(177 µmol/L). An additional nine patients were on renal dialysis prior to elective AAA 
repair8. 
Castagno et al16 investigated the incidence of AKI in both open and endovascular 
repairs of infrarenal AAAs. In the open repair subgroup comprising 285 participants, 
75 patients (26.3%) developed AKI. The study found that those who developed post-
operative AKI had higher pre-operative serum creatinine concentration. Risk factors 
for the development of AKI included: current smoking, hypertension, chronic kidney 
disease, and arrhythmias. 
In the study by Menard et al9, renal failure complicated the post-operative course of 
13 out of the total 572 patients, or 2.3% of their study population. The five-year 
survival rate (5YSR) was worse in those patients with a higher creatinine. Patients 
with a serum creatinine of greater than 3.0 mg/dL (265 µmol/L) had a 5YSR of 11%. 
Comparatively, in those with a serum creatinine of 2.0-3.0 mg/dL (177-265 µmol/L), 
the 5YSR was 45%9.  
Twenty to forty-six percent (20-46%) of patients with ruptured AAAs develop AKI. 
Barratt et al17 looked specifically at the outcomes of patients developing renal failure 
following open repair of ruptured AAA. They retrospectively investigated cases 
admitted to the ICU from 1984 to 1996, excluding those who had had pre-existing, 
dialysis-dependent renal disease. The authors defined acute renal failure as an 
increase of serum creatinine to greater than 600 µmol/L, or the commencement of 
renal replacement therapy for hyperkalaemia, acidosis or fluid overload. Sixty-five 
cases were identified for analysis. It was observed that AKI occurred at a median of 
4 days post-operatively. 75% of those who developed AKI died in hospital. Those 
who developed isolated AKI survived, whereas the development of multi-organ 
failure worsened outcomes. Of the survivors, 56% did not survive beyond five years 
after operation. This study did not report the percentage of patients with ruptured 





4.5. DETECTION OF ACUTE KIDNEY INJURY AND RIFLE/KDIGO 
CLASSIFICATION 
Several groups have attempted to define classify acute kidney injury in recent years. 
In 2004, the Acute Dialysis Quality Initiative (ADQI) workgroup proposed the RIFLE 
(Risk Injury Failure Loss End-stage renal disease) criteria, which utilises glomerular 
filtration rate (GFR) and urine output in order to classify acute kidney injury13, as in 
the table below. 
 GFR criteria Urine output criteria 
Risk Serum creatinine increased 1.5 times <0.5 mL/kg/hour for 6 
hours 
Injury Serum creatinine increased 2.0 times <0.5 mL/kg/hour for 12 
hours 
Failure Serum creatinine increased 3.0 times, 
or creatinine >355 µmol/L when there 
was an acute rise of >44 µmo/L 
<0.3 mL/kg/hour for 24 
hours or anuria for 12 
hours 
Loss Persistent acute renal failure; complete 










Therefore, according to the RIFLE classification, acute renal failure was diagnosed 
when the serum creatinine had exceeded 355 µmol/L, had risen by more than 44 
µmol/L, or had risen by more than three times the baseline creatinine.  
In 2007, the Acute Kidney Injury Network (AKIN), which included members of the 
original ADQI group, proposed a change of terminology from ‘acute renal failure’ to 
‘acute kidney injury’ in order to encapsulate the entire spectrum of renal dysfunction.  
AKIN proposed that a diagnosis of acute kidney injury be made if there was an 
“abrupt (within 48 hours) reduction in kidney function, (then) currently defined as an 
absolute increase in serum creatinine of more than or equal to 26.4 µmol/L, a 
percentage increase in serum creatinine of more than 1.5 times the baseline value, 
or a reduction of urine output (<0.5 ml/kg/hour for 6 hours)”18. The diagnostic criteria 
for AKI closely mirror the criteria for ‘Risk’ under the RIFLE criteria. 
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More recently, there has been recognition of the need to unify global guidelines 
pertaining to the management of acute kidney injury. This is with the aim of 
improving patient outcomes. The Kidney Disease: Improving Global Outcomes 
(KDIGO) foundation in 2012 released clinical practice guidelines, which incorporated 
the RIFLE/AKIN criteria into a single definition, namely: an increase in serum 
creatinine by >0.3 mg/dL (>26.5 µmol/L) within 48 hours; an increase in serum 
creatinine to >1.5 times the baseline within seven days; or a urine volume <0.5 
ml/kg/hour for six hours. 
KDIGO goes on to grade the severity of acute kidney injury: 
 Grade 1: the aforementioned definition of AKI, namely an increase in serum 
creatinine by >0.3 mg/dL (>26.5 µmol/L) within 48 hours; an increase in 
serum creatinine to >1.5 times the baseline within seven days; or a urine 
volume <0.5 ml/kg/hour for six hours 
 Grade 2: serum creatinine increase of 2.0-2.9 times the baseline, or a urine 
output of <0.5 ml/kg/hour for a duration exceeding 12 hours 
 Grade 3: a serum creatinine increase of more than 3.0 times the baseline, a 
serum creatinine of >353.6 µmol/L, initiation of renal replacement therapy, a 
decrease of estimated GFR to <35 ml/min per 1.73m2, or anuria for >24 
hours19 
KDIGO grade 3 correlates with the RIFLE classification: Failure stage. 
Serum creatinine as a marker for renal injury has its limitations, as the production of 
creatinine is dependent on muscle mass. Thus, creatinine may be falsely normal in 
the elderly, who develop sarcopenia. The search continues for the ideal marker of 
acute kidney injury. Several serum and urine biomarkers have been identified as 
being potentially useful in the early detection of renal injury, including serum- and 
urinary neutrophil gelatinase-associated lipocalin (NGAL), serum cystatin C, urinary 
kidney injury molecule 1 (KIM-1) and urinary interleukin 18 (IL-18)20,21. These assays 
are undergoing validation for use in humans, and have not been incorporated into 
any acute kidney injury classification system.  
For the purposes of this dissertation, we chose to use serum creatinine changes in 
order to quantify the severity of acute kidney injury post AAA repair. Serum 
creatinine is an easier parameter to retrospectively audit than urine output in ICU.  
Furthermore, we used KDIGO stage 3 to denote those in need of renal replacement 
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therapy. Tests of serum or urinary biomarkers of renal dysfunction are not yet 
available at Groote Schuur Hospital. 
 
4.6. INSTITUTION OF RENAL REPLACEMENT THERAPY 
The institution of renal replacement therapy is at the discretion of attending 
clinicians. Historically, the indications for dialysis are: 
 Refractory hyperkalaemia 
 Severe or worsening metabolic acidosis 
 Refractory pulmonary oedema 
 Uraemic encephalopathy or pericarditis 
There is no consensus regarding the optimal time to initiate dialysis. General 
consensus is that earlier RRT is associated with lower mortality. In a systematic 
review, Joannidis et al22 concluded that initiating RRT before the onset of uraemic 
symptoms was associated with a better outcome. Bagshaw et al23 demonstrated 
that late initiation of RRT (more than five days from ICU admission) was associated 
with prolonged RRT, hospital stay, and worsened renal recovery. There was, 
however, no definitive serum urea or creatinine concentration identified above which 
to commence RRT.   
The KDIGO guidelines advise clinicians to monitor trends in urea and creatinine, 
rather than single values, when making the decision to institute RRT19. Apart from a 
comment on emergently initiating RRT in the case of life-threatening metabolic 
acidosis, hyperkalaemia or volume overload, KDIGO makes no recommendation on 
the optimal time to initiate RRT. 
 
4.7. TYPES AND COST OF RENAL REPLACEMENT THERAPY 
Renal replacement therapy is a broad term that can be used to describe 
haemodialysis, haemofiltration, haemodiafiltration, peritoneal dialysis and renal 
transplantation. In the post-operative and ICU settings, and for the purpose of this 
review and dissertation, RRT refers to haemodialysis.  
Haemodialysis is broadly divided into two different modalities: namely, intermittent 
haemodialysis and continuous haemodialysis. Intermittent haemodialysis can further 
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be divided into intermittent haemodialysis (IHD), as well as prolonged intermittent 
haemodialysis, otherwise known as sustained low efficiency daily dialysis (SLEDD). 
Continuous venovenous haemodialysis (CVVHD) is the sole example of continuous 
haemodialysis. 
Decisions pertaining to the type of renal replacement therapy instituted are 
determined by the clinical condition of the patient. The different modalities have 
implications on speed of solute and volume removal, and thus affect the patient’s 
haemodynamic profile to varying degrees. CVVHD confers the greatest 
haemodynamic stability to its recipients. IHD is usually administered over a period of 
4-6 hours, during which a large amount of fluid can be removed. It may have a 
negative effect on a patient’s haemodynamics, which has negative implications on 
renal recovery24. SLEDD is occasionally described as a compromise between the 
aforementioned modalities. In a comparison between CVVHD and SLEDD, there 
was some evidence that SLEDD was associated with improved outcome in terms of 
higher post-dialysis mean arterial pressure and subsequently, a lower mortality25. 
The study was carried out on only 101 patients; therefore, that has yet to be tested 
on a larger population.  
Haemodialysis is a costly intervention. Factors which contribute to the high cost 
include human resource costs (staffing), as well as the cost of equipment and 
consumables. In terms of staffing, SLEDD is the cheapest modality. In terms of 
consumables, CVVHD (ZAR 2 727) is the most expensive when compare to IHD 
(ZAR 1 950) and SLEDD (ZAR 2 076). The prices quoted are the daily cost of each 
modality, but also include the initial cost of a vascular catheter, which is usually 
replaced at least every seven days to prevent line-related sepsis. These prices are 
correct as of August 2016.  
Studies looking at the cost-effectiveness of renal replacement therapy must take into 
account patient survival at six months and five years, as well as quality of life. To 
adequately represent long-term cost-effectiveness, researchers utilise the concept 
of quality-adjusted life-years (QALYs). Overall, renal transplantation provides the 
best results in terms of QALYs26. 
In the study carried out by Korkeila et al14, the quoted cost per 6-month survivor as 
USD 80 000, with good quality of life reported by the subjects. Moreover, the 
patients who did not survive ICU tended to have multi-organ failure, which prolonged 
ICU stay. Thus, the cost of care was ultimately greater. 
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4.8   IMPLICATIONS FOR RESEARCH 
To our knowledge, the morbidity and mortality associated with open AAA repair at 
Groote Schuur has not been quantified.  In view of the evidence in literature, this 
audit will focus on examining the mortality of both elective and emergency open 
AAA repair, comparing the mortality at GSH with current global trends.  It will also 
examine the incidence and outcomes of RRT in the post-operative period. For the 
purposes of this dissertation, KDIGO stage 3 will be used to indicate those patients 
who meet the criteria for the institution of RRT. 
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Background: Open AAA repair is a major, high risk surgery and is associated with 
significant morbidity and mortality. Current literature quotes an overall mortality of 
ruptured AAA at 85-90%, including those who do not reach the operating theatre. 
Mortality of elective AAA repairs is 4-8%. Many patients presenting with abdominal 
aortic aneurysms are elderly and have pre-existing medical conditions, therefore 
putting them at high risk for numerous post-operative complications, such as acute 
kidney injury, pulmonary and cardiac complications. These complications lead to 
potentially increased ICU and hospital stays. 
Objectives: To the author’s knowledge, an audit into the morbidity and mortality at 
Groote Schuur Hospital has not yet been formally performed. Such a retrospective 
audit will be useful in establishing where this hospital stands in terms of mortality, as 
compared with published data from international centres. In terms of morbidity, this 
research focused on the development of acute kidney injury following AAA repair. 
Methods: The study design was an observational retrospective file audit, of both 
emergency and elective open abdominal aortic aneurysm repairs. 90 case reports of 
operations performed between October 2006 and December 2014 were analysed. 
The primary outcome measure was the incidence and causes of perioperative (30-
day) mortality. The secondary outcome measure was the incidence of acute kidney 
injury and renal replacement therapy (RRT). We further analysed whether cross-
clamp time and anatomical classification of the aneurysm had any effect on the 
subsequent need for RRT, utilising the Mann-Whitney test. 
Results: Of the 90 patients, 76.7% were male (n=69). The study population had a 
mean age of 64.9 years. Overall perioperative (30-day) mortality of both emergency 
and elective cases was 15 out of 90 cases (16.6%); the mortality for emergency 
cases was 12 out of 31 (38.7%), as compared to 3/59 (5.1%) for elective cases. 
Seventeen patients (18.9%) developed KDIGO stage 3 AKI, and RRT was instituted 
in 12 cases (13.3% of all patients); seven patients survived, and no patients were 
dialysis-dependent on hospital discharge. AKI was not significantly associated with 
abdominal aortic cross-clamp time (46 minutes vs. 38 minutes, p=0.9021), but was 
significantly associated with anatomical classification of the aneurysm (supra-
/juxtarenal vs. infrarenal, p=0.037). 
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Conclusions: In comparison with research from international centres, this study 
population was predominantly male, with a similar age profile to that quoted. The 
bulk of the perioperative mortality was from emergency AAA repairs, with the 
mortality associated with elective open AAA surgical repair being within the ranges 
quoted in international literature. Of the patients who received RRT, there was a 
mortality of 41.6%. There were many limitations in this study, as the population 
analysed was extremely heterogeneous, owing to the small sample size. There is 
great potential for further research, especially into the outcomes of open versus 






















A RETROSPECTIVE AUDIT/STUDY INTO THE MORBIDITY AND MORTALITY 
ASSOCIATED WITH OPEN ABDOMINAL AORTIC ANEURYSM REPAIRS AT 
GROOTE SCHUUR HOSPITAL, CAPE TOWN 
 
INTRODUCTION 
Aortic aneurysm repairs, in various forms, have been performed since the 2nd 
century[1]. The first instance of abdominal aortic ligation was described in 1817, by 
Astley Cooper. Subsequently, significant advances have been made in the 
management of aortic aneurysms, with the modern techniques for open surgical 
repair (OSR) of abdominal aortic aneurysms (AAA) being developed in the 1940s 
and 1950s[1]. Endovascular repair of abdominal aortic aneurysms (EVAR)  was 
introduced as an alternative to open repair in the early 1990s[2]. Despite the 
subsequent refinement of the endovascular technique, open abdominal aortic 
aneurysm (AAA) repair is still considered an important complementary treatment 
strategy, as it is still essential in patients who are not endo-suitable, or have a life 
expectancy exceeding five to ten years. 
Open AAA repair is associated with significant morbidity and mortality, and remains 
classified as major, high-risk surgery. Published literature from centres in the UK 
reports a postoperative mortality of elective AAA repairs of 4-8%. The mortality rate 
of emergency open AAA repairs remains significantly higher, being 80-85%[3]. 
Data regarding the incidence of aortic aneurysms emanates predominantly from the 
developed world, currently reported as ~ 1.5% - 5%, where the life expectancy is 
greater (78.7 years in the US and 81.5 years in the UK) and health systems 
preferentially geared towards prevention, surveillance and treatment of AAA. 
The magnitude of the problem in South Africa is difficult to ascertain, as there are 
limited published data. Abdominal aortic aneurysm is more prevalent in the adult 
Caucasian male population above 65 years. South Africa, as a developing country, 
has experienced an increase in life expectancy.  As of 2015, national life expectancy 
stands at 61 years, having increased from 52 years in 2005[4]. It is reasonable to 
expect that there will be an increase in the incidence of AAAs as the population 
ages. At the moment, one can only speculate that the South African AAA case load 
is far lower than that of developed countries. A study by Tiemensma et al[5] 
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conducted in South Africa suggested that 1.3% of cases of sudden and unexpected 
death (8/601) were determined at autopsy to be due to ruptured aortic aneurysm. 
South Africa is a severely resource-constrained developing country. Renal 
replacement therapy (RRT) is a resource-intensive intervention, and the 
development of acute renal failure in hospital is an independent predictor of mortality 
in all patients, and especially in patients undergoing open surgical AAA repair[6,7,8]. 
Questions are often raised as to whether instituting RRT is cost effective in terms of 
patient survival and quality of life post open surgical AAA repair. In observing the 
ethical principle of distributive justice, there is a need to ensure that resources 
benefit the majority of the population. 
 
RATIONALE FOR RESEARCH 
Groote Schuur Hospital (GSH) in Cape Town, South Africa, is the major academic 
hospital affiliated with the University of Cape Town. The vascular surgery unit at GSH 
receives referrals from the Cape Metropolitan area and as far afield as East London, 
approximately 1000 kilometres from Cape Town. Based on the number of entries in 
theatre ledgers, it is estimated that an average of 14 patients undergo open AAA repair 
annually. 
All patients undergoing open AAA repair at GSH are admitted to the intensive care unit 
(ICU) for post-operative care. These patients are at risk of acute kidney injury and may 
require renal replacement therapy, potentially leading to prolonged hospital stays. 
Lengthy hospital stays, including total ICU stays, are costly for the health system, as well 
as for the patient, who is required to pay for hospital services while losing his or her 
income due to incapacity. According to the author’s knowledge, there has not been a 
study conducted at GSH into the outcomes of these specific patients. 
The primary objective of this research is to establish the perioperative (30-day) mortality 
associated with open AAA repair at GSH. The secondary objective is to determine 
whether a significant portion of patients who had an open AAA repair developed a need 






The design of the study was a retrospective observational study, which uses existing 
data that have been recorded for reasons other than research. 
The study population included all patients who underwent open AAA repair at GSH 
between October 2006 and December 2014. Because the numbers of patients 
operated upon was relatively small, the author included both elective and 
emergency open AAA repairs. Patients who received an open or hybrid thoraco-
abdominal aortic aneurysm repair, or an endovascular AAA repair (EVAR) were 
excluded from this study. Patients with incomplete clinical records were also 
excluded from this study. 
Data from clinical hospital records, anaesthetic and vascular operative databases, 
were capture and recorded in clinical research folders created for each patient. Data 
capture included: patient age, gender, risk factors for AAA, and associated co-
morbidities as documented in the hospital admission notes. 
Abdominal aortic aneurysms were classified as infrarenal, juxtarenal (infrarenal neck 
less than 8 mm) or supra-renal based on preoperative Computed Tomographic 
Angiogram (CTA) imaging. The position of the abdominal aortic cross-clamp, as well 
as the duration of cross-clamp, was recorded from the operative and anaesthetic 
records. Post-operative data collection included: duration of ICU and hospital stay, 
change in creatinine, type and duration of RRT instituted and whether there was a 
need for outpatient RRT following hospital discharge. The 30-day mortality was 
recorded using hospital records as well as the national births and deaths registry. 
Data on serum creatinine concentrations were obtained from the National Health 
Laboratory Service’s Disa electronic database, and hospital records. Data pertaining 
to acute kidney injury, as defined by the Kidney Disease Improving Global 
Outcomes (KDIGO) working group, and the need for renal replacement therapy, 
were recorded. In this study, acute renal failure was defined  as serum creatinine 
levels meeting the criteria for KDIGO Stage 3 renal injury, namely: an increase in 
serum creatinine of more than three times of the preoperative value, a serum 
creatinine of greater than, or equal to, 353.6 µmol/L, or the institution of renal 
replacement therapy[13]. Urine output criteria was not used, as there is great 
interpersonal variability in the accurate recording thereof. 
34 
 
Data were captured electronically on Microsoft Excel™ spread sheets. Data analysis 
was performed using Stata 13™. Secondary analyses were carried out using the 
Mann-Whitney and Fischer’s Exact tests. 
Ethical approval to perform the audit was obtained from the Human Research Ethics 
Committee of the Faculty of Health Sciences, University of Cape Town (HREC 
reference number 914/2014). As no public electronic database of operations exists 
in the study setting, the researcher perused theatre ledgers of operations performed 
between October 2006 and December 2014, and identified all open abdominal aortic 
aneurysm repairs performed during that time. 
 
RESULTS 
One hundred and four open AAA repairs were performed during the study period 
October 2006 to December 2014. Of the 104 cases, 90 folders were retrieved from 
medical records. Fourteen patients were excluded because of inadequate clinical 
records. These 90 patients therefore constitute the study population. 
The study population consisted of 76.7% (n=69) males and 23.3% (n=21) females. 
The mean age of the sample was 64.9 years (median 68 years, interquartile range 
60-71 years). The minimum and maximum ages were 31 and 84 years respectively. 
Seventy six percent (76.67%) of the patients had documented pre-operative 
hypertension and 30% had ischaemic heart disease, 28.9% had hyperlipidaemia, 
6.67% were HIV (human immunodeficiency virus) positive, and 10% had established 
chronic kidney disease. Furthermore, 64.77% of patients were smokers, with 20.0% 
reported to have moderate to severe chronic obstructive pulmonary disease (COPD) 
based on clinical and radiological features and pulmonary function tests. (Table 1) 
Of the 90 patients in the study, 65.6% (n=59) required elective open AAA repairs 
and 34.4% (n=31) required emergency open AAA repairs, 29 of these being for 
ruptured AAAs. With respect to the AAA classification, 61.1% (n=55) of the 
aneurysms repaired were infrarenal, with 37.8% (n=34) being juxtarenal, and only 
one case (1.1%) being suprarenal. 
The perioperative (30-day) mortality rate (combined elective and emergency cases) 
was 16.6% (n=15). Most of the mortalities (n=12) followed emergency AAA repair. 
Most of the perioperative mortality was associated with emergency open AAA 
35 
repairs (12/31, 38.7%). The mortality in the elective repair group was much lower, at 
5.1% of all elective repairs. (Table 2) 
One elective patient survived in-hospital for 42 days, until succumbing to a 
suspected pulmonary embolism. The mean hospital length of stay in survivors was 
11.71 days. In non-survivors, the mean survival was 10.31 days. The mean length of 
ICU stay was 4.09 days. (Table 3) 
Aortic cross-clamp time was not recorded in 4 of the cases.  Of the remaining 86 
cases, the mean cross-clamp time was 39 minutes (median 32 minutes, IQR 24-55 
minutes). An analysis of aortic cross-clamp times was performed according to the 
level of clamping. (Table 4) 
The study identified 17 patients (18.9%) who developed KDIGO stage 3 renal 
dysfunction post-operatively. Three of those patients had pre-existing chronic kidney 
disease. Two patients had diabetes mellitus, and 15 patients had hypertension. One 
patient was HIV positive. Only 12 patients received RRT (13.3% of all patients). Of 
the 5 patients not commenced on RRT, two had a poor prognosis, and the other 
three patients had adequate urine output despite deranged serum creatinine 
concentration. Of the 12 patients who received RRT, five did not survive. Of the 
survivors, no patients were dialysis dependent at hospital discharge. 
In a Mann-Whitney analysis of renal replacement therapy and aortic cross-clamp 
times, there was no significant difference in cross-clamp times between those 
patients who received RRT and those who did not (46 minutes versus 38 minutes, 
p=0.9021). Eight of the patients who received RRT had supra- and juxtarenal 
aneurysm; this was statistically significant (p=0.037). The type of RRT employed 
initially was continuous venovenous haemodialysis (CVVHD) in five patients, 
sustained low efficiency daily dialysis (SLEDD) in four patients, and intermittent 
haemodialysis (IHD) in three patients. The mean duration of RRT was 7.58 days 
(median 4 days, range 1- 20 days). 
DISCUSSION 
Patients presenting with AAA tend to be elderly and have numerous comorbidities. 
Potent risk factors for the development of AAA include: age of greater than 65 years, 
smoking and a  positive family history of AAA[3]. The one consistent and modifiable 
factor associated with accelerated growth of aortic aneurysms is cigarette smoking, 
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with hypertension also contributing to aneurysm growth[9,10]. The normal adult aorta 
has a diameter of approximately 1.7-2.2 cm. Any abdominal aortic diameter beyond 
3 cm or greater is classified as an abdominal aortic aneurysm. Elective open AAA 
repairs are indicated in all conventional risk patients with a symptomatic AAA 
irrespective of diameter, or an asymptomatic AAA that fulfils the one of the following 
criteria: diameter greater than 5.5 cm in males and 5.0 cm in females; saccular AAA 
diameter greater than 3 cm; or an associated iliac aneurysm with a diameter greater 
than 3 cm.  For asymptomatic small AAA (4-5.5 cm in diameter), there is no survival 
advantage for OSR compared to surveillance and deferred repair[11]. 
Various risk factors for perioperative (30-day) mortality have been identified, 
including advanced age, smoking status, low forced expiratory volume in one 
second (FEV1), pre-existing myocardial ischaemia, and a pre-operative serum 
creatinine greater than 160 µmol/L. Other, non-patient related risk factors included 
hospital case volumes, graft type, professional rank of surgeon, and surgeon case 
volumes and expertise (the number of AAA operations the surgeon had performed 
during the trial)[11]. 
Perioperative morbidity includes complications such as acute renal failure, acute 
pulmonary complications, colonic ischemia, myocardial ischemia and infarction, 
acute thrombo-embolic lower extremity complications, prolonged ileus, and paralysis 
due to spinal cord ischemia[12]. 
This study showed a similar mean age as is quoted in literature, with a similar risk 
profile, namely, hypertension, hyperlipidaemia, ischaemic heart disease and COPD. 
The study population had a 6.7% incidence of HIV; this is often not reported in the 
literature from developed countries. HIV infection tended to be in the younger 
patients (mean age 43.3 years) in this study. HIV infection is associated with the 
development of atypical aneurysm, postulated to be due either to opportunistic 
infections or accelerated atherosclerotic processes[13]. With an HIV infection 
prevalence of 10.2%[4], South African institutions will invariably encounter more of 
these atypical aneurysms. 
In studies performed in countries in the developed world, elective AAA repairs carry 
a mortality of 4-8%, whereas emergency AAA repairs carry a much higher mortality 
of 85-90%[3]. In most of these studies, the researchers have focussed on outcomes 
following repair of infrarenal AAAs. In this study population, there were comparable 
mortality rates. The mortality among the elective AAA repair group (5.1%) is within 
the range quoted in literature. 
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Direct comparisons with international studies regarding renal failure are difficult to 
make, as wide variations exist in the definition of renal failure and in the timing of 
RRT. Most articles place the rate of renal failure in elective AAA repairs at 2%[14,15]. 
The incidence of renal failure following ruptured AAA repair is higher, at 20-46%[7]. 
The results showed that 17 of our patients (18.9%) developed acute kidney injury 
post open AAA repair, having fulfilled the criteria for KDIGO stage 3, which is 
analogous to the RIFLE criteria Failure stage[16]. Of the 12 patients who did receive 
RRT, five were emergency cases. At GSH, the decision to institute RRT was 
discretionary, and made by the attending nephrologist, as well as the intensivist who 
referred the patient to nephrology.  The perioperative mortality rate in the RRT group 
was 41.67%. It is known that the development of acute renal failure is associated 
with an in-hospital mortality of 45%[17], and that the long-term prognosis is negatively 
impacted[17,15]. 
This study also found that duration of aortic cross-clamp time was not a significant 
factor in the subsequent development of renal failure. However, the anatomical 
classification of the AAA did seem to play a role in the subsequent development of 
renal failure. Juxta- and suprarenal aneurysms constituted the bulk of the patients 
receiving RRT (77.1%, p=0.037), presumably due to the level of cross-clamp 
placement and a greater burden of ischaemia. A similar observation was made by 
Crawford et al[18] in a study published in 1986. More recently, Chong et al[19] 
investigated the differences in outcomes in infrarenal and juxta-/suprarenal 
aneurysm (collectively termed suprarenal) repairs. They demonstrated a greater 
decline in renal function in the suprarenal group; mortality was not significantly 
different in these two groups. 
Five patients were initiated on CVVHD, with another four initiated on SLEDD. Two of 
these patients were later placed onto the less labour intensive, and cheaper, IHD. 
Only three patients were placed on IHD as the first modality of RRT.  At an 
estimated daily cost of ZAR 2 727 for CVVHD, ZAR 2 076 for SLEDD and  
ZAR 1 950 for IHD, the costs of RRT accrue[20].  The choice of RRT modality used is 
made by the attending renal physicians at Groote Schuur Hospital. This is informed 
not only by the patient’s haemodynamic status, but also by the renal unit’s staffing 
constraints. 
Renal recovery, and subsequent quality of life, is an important consideration in 
patients who receive RRT. The on-going need for RRT would have an impact on the 
quality of life of these patients, in addition to placing additional financial burdens on 
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the patients and the healthcare system. Lin et al[8] found that 84.7% of survivors do 
recover their renal function following a period of dialysis. In this study population, 
none of our patients were dialysis dependent upon hospital discharge, and so did 
not face on-going financial constraints from the need to continue outpatient dialysis. 
 
LIMITATIONS OF RESEARCH 
The biggest challenge faced in carrying out this research was the inadequate clinical 
records in 14 patients. With the small number of cases retrieved, the author elected 
not to separate the different data sets between emergency and elective, or infrarenal 
and juxta-/suprarenal aneurysms in our sample; therefore, the patient population 
was heterogeneous. The small sample size also impacted on the ability to carry out 
univariate or multivariate analyses on the risk associations for the development of 
acute kidney injury. Conclusions regarding modifiable risk factors or preventative 
strategies can therefore not be made, but may signal future areas for research.  A 
future study would also need to also look at long-term clinical outcomes. 
 
CONCLUSIONS 
This study confirmed in a local South African retrospective institutional audit that 
open AAA repairs are still associated with significant mortality and renal dysfunction. 
Perioperative mortality was similar to other international centres, at 5.1% and 38.7% 
for elective and emergency repairs respectively, with mortality in those requiring 
RRT being considerably high (41.67%), but definitely not futile. This has implications 
on the resource utilisation in providing these patients with renal support. The one 
factor found to have a bearing on the need for post-operative RRT, apart from pre-
existing chronic kidney disease, is the anatomical classification of the abdominal 
aortic aneurysm (p=0.037). At this time, it is not prudent to draw any conclusions, as 
a larger number of patients would need to be studied. 
The relatively small annual number of open AAA repairs at Groote Schuur is most 
likely indicative of a lower incidence of AAAs in the relatively young, predominantly 
black, South African population. 
A number of questions arise from this study. Are there any modifiable risk factor 
associations contributing to the development of acute kidney injury? Do patients 
undergoing endovascular repair of AAAs in South Africa have better renal 
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outcomes? What role does HIV play in the development of renal complications? 
What are the perioperative renal outcomes in patients with inflammatory 
aneurysms? 
Current clinical practice suggests AAA is also being diagnosed and treated in mixed 
ethnic populations. More atypical AAAs are being diagnosed and treated in the black 
population, whereas AAA is rare in Asian populations in South Africa. This study 
was not designed to examine the differences in racial groups in terms of type of 
aneurysm and age of operation. This is a potential future area of research. 
The establishment of a computerised database of clinical records would definitely 
facilitate retrieval and analysis of outcome data. Multi-centre studies incorporating 
data from different centres in South Africa is also lacking. This further highlights the 
problem of a lack of research reflecting perioperative outcomes in the South African 
context, a problem which is gradually being addressed. 
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Table 1 Baseline data 
 N (%) 













Positive smoking history 57 (64.8%) 
Comorbidities 
Hypertension 
































 * Percentage of all emergency cases 
 †Percentage of all elective cases 
 
 
Table 2 Cause of death 
Cause of death N=15 
Cardiovascular 









Multi-organ failure, including renal 2 
Gut ischaemia 1 
Sepsis          2 






Table 3 Duration of ICU and hospital stay 
Mean SD p50 p25 p75 Min Max 
Duration of ICU stay (days) 4.09 3.25 3.5 2 5 1 22 
Duration of postoperative 
ventilation (days) 
1.16 2.20 0 0 1 0 14 


























Table 4 Duration of abdominal aortic cross-clamp 
Clamp position N Mean SD p50 p25 p75 Min Max 
Infrarenal 29 49.69 21.74 49 32 61 15 100 
Suprarenal 29 34.31 18.27 25 24 40 9 83 
Supracoeliac 28 34.14 27.19 26 21.5 35.5 8 150 
Total 86 39.44 23.55 32 24 55 8 150 
Mean, SD, p50, p25, p75, min and max in minutes 
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Data Capture Form 
Study number: ________________________________                                                                                                                                
Folder number:  ________________________________ 
Date of operation:  _____________________________ 
Date of birth: _______________________ Age at operation: _______________ 
Gender: _______________ 
Type of aneurysm: Saccular / Fusiform (Circle applicable one) 
Position of aneurysm: Suprarenal / Juxtarenal / Infrarenal (Circle applicable one) 
Position of aortic cross-clamp: Supracoeliac / Suprarenal / Infrarenal (Circle 
applicable one) 
Total aortic cross-clamp time (minutes): _________________ 
Indicate: Emergency / Elective    Ruptured? Yes / No 
Patient comorbidities:          
            
            
            
Date of ICU admission:        
Date of ICU discharge:       
ICU length of stay (days):      
Days ventilated:           
Date of death:           
Cause of death:           
Renal replacement therapy (RRT): Yes / No   
Number of days on RRT:     
Type of RRT:            
Creatinine on admission to hospital (prior to operation):      
Creatinine on commencement of RRT:        
Creatinine on hospital discharge/death:        
Date of last recorded creatinine prior to discharge/death:      
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Dialysis dependent at hospital discharge: Yes / No 
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 Guest editorial 
 Continuing Medical Education (CME) 
  
*Contact claudian@hmpg.co.za for information on submitting ad hoc/commissioned 
supplements, including guidelines, conference/congress abstracts, Festschrifts, etc. 
  
Authorship 
Named authors must consent to publication. Authorship should be based on: (i) 
substantial contribution to conceptualisation, design, analysis and interpretation of 
data; (ii) drafting or critical revision of important scientific content; or (iii) approval 
of the version to be published. These conditions must all be met (uniform 
requirements for manuscripts submitted to biomedical journals; refer to 
www.icmje.org) 
  
If authors’ names are added or deleted after submission of an article, or the order of 
the names is changed, all authors must agree to this in writing. 
  
Please note that co-authors will be requested to verify their contribution upon 
submission. Non-verification may lead to delays in the processing of submissions. 
   
Conflicts of interest 
Conflicts of interest can derive from any kind of relationship or association that may 
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all the information they need to enable them to make an informed assessment about a 
publication’s message and conclusions. We require that both authors and reviewers 
declare all sources of support for their research, any personal or financial 
relationships (including honoraria, speaking fees, gifts received, etc) with relevant 
individuals or organisations connected to the topic of the paper, and any association 
with a product or subject that may constitute a real, perceived or potential conflict of 
interest. If you are unsure whether a specific relationship constitutes a conflict, 
please contact the editorial team for advice. If a conflict remains undisclosed and is 
later brought to the attention of the editorial team, it will be considered a serious 




Research ethics committee approval 
Authors must provide evidence of Research Ethics Committee approval of the 
research where relevant. Ensure the correct, full ethics committee name and 
reference number is included in the manuscript. 
If the study was carried out using data from provincial healthcare facilities, or 
required active data collection through facility visits or staff interviews, approval 
should be sought from the relevant provincial authorities. For South African authors, 
please refer to the guidelines for submission to the National Health Research 
Database. Research involving human subjects must be conducted according to the 
principles outlined in the Declaration of Helsinki. Please refer to the National 
Department of Health’s guideline on Ethics in Health research: principles, 
processes and structuresto ensure that the appropriate requirements for conducting 
research have been met, and that the HPCSA’s General Ethical Guidelines for 
Health Researchershave been adhered to. 
  
Clinical trials  
Since 1
st
 December 2005, all clinical trials conducted in South Africa have been 
required to be registered in the South African National Clinical Trials Register. The 
SAMJ therefore requires that clinical trials be registered in the relevant public trials 
registry at or before the time of first patient enrollment as a condition for publication. 
The trial registry name and registration number must be included in the manuscript.  
  
Protection of rights to privacy 
Patient 
Information that would enable identification of individual patients should not be 
published in written descriptions, photographs, and pedigrees unless the information 
is essential for scientific purposes and the patient (or parent or guardian) has given 
informed written consent for publication and distribution. We further recommend 
that the published article is disseminated not only to the involved researchers but also 
to the patients/participants from whom the data was drawn. Refer to Protection of 
Research Participants. The signed consent form should be submitted with the 





Any individual who is identifiable in an image must provide written agreement that 
the image may be used in that context in the SAMJ. 
  
Copyright notice 
Copyright remains in the Author’s name. The work is licensed under a Creative 
Commons Attribution - Noncommercial Works License. Authors are required to 
complete and sign an Author Agreement form that outlines Author and Publisher 
rights and terms of publication. The Author Agreement form should be uploaded 
along with other submissions files and any submission will be considered incomplete 
without it. 
   
Material submitted for publication in the SAMJ is accepted provided it has not been 
published or submitted for publication elsewhere. Please inform the editorial team if 
the main findings of your paper have been presented at a conference and published in 
abstract form, to avoid copyright infringement. The SAMJ does not hold itself 
responsible for statements made by the authors. 
Previously published images 
If an image/figure has been previously published, permission to reproduce or alter it 
must be obtained by the authors from the original publisher and the figure legend 
must give full credit to the original source. This credit should be accompanied by a 
letter indicating that permission to reproduce the image has been granted to the 
author/s. This letter should be uploaded as a supplementary file during submission. 
  
Privacy statement 
The SAMJ is committed to protecting the privacy of its website and submission 
system users. The names, personal particulars and email addresses entered in the 
website or submission system will not be made available to third parties without the 
user’s permission or due process. By registering to use the website or submission 
system, users consent to receive communication from the SAMJ or its publisher 
HMPG on matters relating to the journal or associated publications. Queries with 
regard to privacy may be directed to publishing@hmpg.co.za. 
  
Ethnic/race classification 
Use of racial or ethnicity classifications in research is fraught with problems. If you 
choose to use a research design that involves classification of participants based on 
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race or ethnicity, or discuss issues with reference to such classifications, please 
ensure that you include a detailed rationale for doing so, ensure that the categories 
you describe are carefully defined, and that socioeconomic, cultural and lifestyle 
variables that may underlie perceived racial disparities are appropriately controlled 
for. Please also clearly specify whether race or ethnicity is classified as reported by 
the patient (self-identifying) or as perceived by the investigators. Please note that is 
not appropriate to use self-reported or investigator-assigned racial or ethnic 
categories for genetic studies. 
  
Continuing Professional Development (CPD) 
SAMJ is an HPCSA-accredited service provider of CPD materials. Principal authors 
can earn up to 15 CPD continuing education units (CEUs) for publishing an article; 
co-authors are eligible to earn up to 5 CEUs; and reviewers of articles can earn 3 
CEUs. Each month, SAMJ also publishes a CPD-accredited questionnaire relating to 
the academic content of the journal. Successful completion of the questionnaire with 
a pass rate of 70% will earn the reader 3 CEUs. Administration of our CPD 
programme is managed by Medical Practice Consulting. To complete questionnaires 
and obtain certificates, please visit MRP Consulting 
  
Manuscript preparation 
Preparing an article for anonymous review 
  
To ensure a fair and unbiased review process, all submissions are to include an 
anonymised version of the manuscript. The exceptions to this are Correspondence, 
Book reviews and Obituary submissions. 
  
Submitting a manuscript that needs additional blinding can slow down your review 
process, so please be sure to follow these simple guidelines as much as possible: 
 An anonymous version should not contain any author, affiliation or particular 
institutional details that will enable identification. 
 Please remove title page, acknowledgements, contact details, funding grants 
to a named person, and any running headers of author names. 
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will be returned to the author(s) for correction, which will delay publication. 
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 Manuscripts must be written in UK English. 
 The manuscript must be in Microsoft Word or RTF document format. Text 
must be single-spaced, in 12-point Times New Roman font, and contain no 
unnecessary formatting (such as text in boxes). 
 Please make your article concise, even if it is below the word limit. 
 Qualifications, full affiliation (department, school/faculty, institution, city, 
country) and contact details of ALL authors must be provided in the 
manuscript and in the online submission process. 
 Abbreviations should be spelt out when first used and thereafter used 
consistently, e.g. 'intravenous (IV)' or 'Department of Health (DoH)'. 
 Scientific measurements must be expressed in SI units except: blood pressure 
(mmHg) and haemoglobin (g/dL). 
 Litres is denoted with an uppercase L e.g. 'mL' for millilitres). 
 Units should be preceded by a space (except for % and ºC), e.g. '40 kg' and 
'20 cm' but '50%' and '19ºC'. 
 Please be sure to insert proper symbols e.g. µ not u for micro, a not a for 
alpha, b not B for beta, etc. 
 Numbers should be written as grouped per thousand-units, i.e. 4 000, 22 160. 
 Quotes should be placed in single quotation marks: i.e. The respondent stated: 
'...' 
 Round brackets (parentheses) should be used, as opposed to square brackets, 
which are reserved for denoting concentrations or insertions in direct quotes. 
 If you wish material to be in a box, simply indicate this in the text. You may 
use the table format –this is the only exception. Please DO NOT use fill, 
format lines and so on. 
  




 In Practice and Case reports 
 Reviews 
 Clinical trials 
 Correspondence 
 Obituaries 






Guideline word limit: 4 000 words 
  
Research articles describe the background, methods, results and conclusions of an 
original research study. The article should contain the following sections: 
introduction, methods, results, discussion and conclusion, and should include a 
structured abstract (see below). The introduction should be concise – no more than 
three paragraphs – on the background to the research question, and must include 
references to other relevant published studies that clearly lay out the rationale for 
conducting the study. Some common reasons for conducting a study are: to fill a gap 
in the literature, a logical extension of previous work, or to answer an important 
clinical question. If other papers related to the same study have been published 
previously, please make sure to refer to them specifically. Describe the study 
methods in as much detail as possible so that others would be able to replicate the 
study should they need to. Results should describe the study sample as well as the 
findings from the study itself, but all interpretation of findings must be kept in the 
discussion section, which should consider primary outcomes first before any 
secondary or tertiary findings or post-hoc analyses. The conclusion should briefly 
summarise the main message of the paper and provide recommendations for further 
study. 
  
Select figures and tables for your paper carefully and sparingly. Use only those 
figures that provided added value to the paper, over and above what is written in the 
text. 
Do not replicate data in tables and in text. 
  
Structured abstract 
 This should be 250-400 words, with the following recommended headings: 
o Background: why the study is being done and how it relates to other 
published work. 
o Objectives: what the study intends to find out 
o Methods: must include study design, number of participants, 
description of the intervention, primary and secondary outcomes, any 
specific analyses that were done on the data. 
o Results: first sentence must be brief population and sample 
description; outline the results according to the methods described. 
Primary outcomes must be described first, even if they are not the 
most significant findings of the study. 
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o Conclusion: must be supported by the data, include recommendations 
for further study/actions. 
 Please ensure that the structured abstract is complete, accurate and clear and 
has been approved by all authors. 
 Do not include any references in the abstracts. 
  
  
Here is an example of a good abstract. 
  
Main article 
All articles are to include the following main sections: Introduction/Background, 
Methods, Results, Discussion, Conclusions. 
The following are additional heading or section options that may appear within these: 
 Objectives (within Introduction/Background): a clear statement of the main 
aim of the study and the major hypothesis tested or research question posed 
 Design (within Methods): including factors such as prospective, 
randomisation, blinding, placebo control, case control, crossover, criterion 
standards for diagnostic tests, etc. 
 Setting (within Methods): level of care, e.g. primary, secondary, number of 
participating centres. 
 Participants (instead of patients or subjects; within Methods): numbers 
entering and completing the study, sex, age and any other biological, 
behavioural, social or cultural factors (e.g. smoking status, socioeconomic 
group, educational attainment, co-existing disease indicators, etc)that may 
have an impact on the study results. Clearly define how participants were 
enrolled, and describe selection and exclusion criteria. 
 Interventions (within Methods): what, how, when and for how long. 
Typically for randomised controlled trials, crossover trials, and before and 
after studies. 
 Main outcome measures (within Methods): those as planned in the protocol, 
and those ultimately measured. Explain differences, if any. 
  
Results 
 Start with description of the population and sample. Include key 
characteristics of comparison groups. 
 Main results with (for quantitative studies) 95% confidence intervals and, 
where appropriate, the exact level of statistical significance and the number 




 Do not replicate data in tables and in text. 
 If presenting mean and standard deviations, specify this clearly. Our house 
style is to present this as follows: 
 E.g.: The mean (SD) birth weight was 2 500 (1 210) g. Do not use the ± 
symbol for mean (SD). 
 Leave interpretation to the Discussion section. The Results section should just 
report the findings as per the Methods section. 
  
Discussion 
Please ensure that the discussion is concise and follows this overall structure – sub-
headings are not needed: 
 Statement of principal findings 
 Strengths and weaknesses of the study 
 Contribution to the body of knowledge 
 Strengths and weaknesses in relation to other studies 
 The meaning of the study – e.g. what this study means to clinicians and 
policymakers 
 Unanswered questions and recommendations for future research 
  
Conclusions 
This may be the only section readers look at, therefore write it carefully. Include 
primary conclusions and their implications, suggesting areas for further research if 
appropriate. Do not go beyond the data in the article. 
  
Editorials 
Guideline word limit: 1 000 words 
  
These opinion or comment articles are usually commissioned but we are happy to 
consider and peer review unsolicited editorials. Editorials should be accessible and 
interesting to readers without specialist knowledge of the subject under discussion 
and should have an element of topicality (why is a comment on this issue relevant 
now?) There should be a clear message to the piece, supported by evidence. 
Please make clear the type of evidence that supports each key statement, e.g.: 
 expert opinion 
 personal clinical experience 




 systematic reviews. 
  
CME 
CME is intended to provide readers with practical, up-to-date information on medical 
and related matters. It is aimed at those who are not specialists in the field. 
From January 2016, all CME articles will be printed in full in the SAMJ. Please try to 
adhere strictly to the guidelines on word count as we have a page limit for the print 
issue of the SAMJ. We reserve the right to place some tables and reference lists 
online if this is necessary for space. 
In practice, this means that each CME topic usually covers two issues of the print 
issue of the SAMJ. 
  
The guest editor, in consultation with the editor, is responsible for convening a team 
of authors, deciding on the subjects to be covered and for reviewing the manuscripts 
submitted. The suggestion is for 4 - 5 articles, although there is some room for 
flexibility contingent on discussions with the editor. 
  
For queries about these guidelines please feel free to contact the CME editor, Dr 
Bridget Farham, by email (ugqirha@iafrica.com) or telephone (+27 (0)21 789 2331). 
  
Review process 
The guest editor reviews the articles and returns them to the CME editor for review 
and final approval. 
  
Guest editorials 
Guideline word limit: 1 000 words 
 Include the guest editor’s personal details (qualifications, positions, 
affiliation, e-mail address, and a short personal profile (50words)). 
 If possible, include a photograph of the author(s) at high enough resolution 
for print. It is preferable to provide two guest editorials, one for each issue, so 





Guideline word limit: 2 000 - 3 000 words 
 Each article requires an abstract of ±200 words. 
 The editor reserves the right to shorten articles but will send a substantially 
shortened article back for author approval. 
  
Personal details 
Please supply: Your qualifications, position and affiliations and MP number (used 
for CPD points); Address, telephone number and fax number, and your e-mail 
address; and a short personal profile (50words)and a few words about your current 
fields of interest. 
  
In Practice 
Guideline word limit: 2 000 - 3 000words 
  
This section includes articles that would previously have been accepted into the 
Forum section, and case reports. 
In practice articles are those that draw attention to specific issues of clinical, 
economic or political interest regarding medicine and healthcare in southern Africa. 
They are assigned to a topic: 
  
 Case report 
 Clinical practice 
 Clinical alert 
 Issues in medicine 
 Issues in public health 
 Healthcare delivery 
 Consensus/Position statement 
 Medicine and the environment 
 Medicine and the law 
 Cochrane corner 
  
  
An In Practice article should follow the following format – sub-headings are not 
necessary, but may be used for clarity: 
61 
 
 Author affiliations and qualifications: to be the same as for Research. Provide 
all authors’ names and initials, qualifications and full affiliations, and 
corresponding author. 
 Short abstract: does not need to be structured, but should capture the essential 
features of the article 
 Introduction: the reason for the article and the issue being addressed 
 Recent research, discussion, local policy around the issue – include your own 
research where appropriate 
 All statements should be referenced and, if opinion only, this should be stated 
 Discussion: how this article adds to the discussion around a particular topic 
 If a clinical practice or policy point is at issue, this needs to be emphasised, 
using a box with highlights if appropriate. 
  
Essentially In practice is an opportunity for a more discursive approach to topics of 
clinical, economic or political importance in southern African health systems. It is 
not an opportunity to put forward unsubstantiated opinions! 
  
Case reports 
The SAMJ has recently started to accept case reports. The cases must come from 
Africa, preferably southern Africa unless the condition is common to all African 
countries, and must be either a completely new description of a clinical condition or 
result (use Google!) or a case that highlights important practice or management 
issues. 
  
Please use the following format for case reports: 
 Title of case: do not include the words ‘a case report’ in the title 
 Summary/abstract:  up to 150 words summarising the case presentation and 
outcome 
 Background: why is this case important and why did you write it up? 
 Case presentation: presenting features, medical, social, family history as 
appropriate 
 Case management: should be according to best practice, and if not, please 
explain why 
 Investigations, if relevant: save space by simply saying ‘normal’ if, for 
example, renal function was completely normal, rather than listing normal 
results, highlight the abnormal – or indeed the normal if this is clinically 
significant 
 Differential diagnosis, if relevant 
 Treatment, if relevant 
 Outcome and follow-up 
 Discussion – a VERY BRIEF review of similar published cases 
 Teaching points: 3 - 5 bullet points 
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 References: as per the SAMJ house style 
 Tables and figures: keep to a minimum. Use clinical images where relevant – 
we need hi-res versions for print, and identifiable persons must have a 
consent form 
 Patient consent: please include a statement about patient consent to a written 
case report. This should be uploaded as a supplementary file. 
  
Clinical trials 
Guideline word limit: 4000 words 
  
As per the recommendations published by the International Committee of Medical 
Journal Editors (ICMJE), clinical trial research is any research that assigns 
individuals to an intervention, with or without a concurrent comparison/control group 
to study the cause-and-effect relationship between the intervention and health 
outcomes. All clinical trials should be registered with the appropriate national 
clinical trial registry (or any international primary register, if relevant), and the trial 
registration number should be cited at the end of the abstract. Since 1
st
 December 
2005, all clinical trials conducted in South Africa have been required to be registered 
in the South African National Clinical Trials Register. The SAMJ therefore requires 
that clinical trials be registered in the relevant public trials registry at or before the 
time of first patient enrollment as a condition for publication. The trial registry name 
and registration number must be included in the manuscript. 
  
Please refer to the general guidelines for all papers at the top of this article for 
additional requirements with respect to ethics approval, funding, author 
contributions, etc. The format of original research articles should be followed for 
reporting of clinical trial results. 
  
Review articles 
Guideline word limit: 4 000 words 
  
These are welcome, but should be either commissioned or discussed with the Editor 
before submission. A review article should provide a clear, up-to-date account of the 
topic and be aimed at non-specialist hospital doctors and general practitioners. 
  
Please ensure that your article includes: 
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 Abstract: unstructured, of about 100-150 words, explaining the review and 
why it is important 
 Methods: Outline the sources and selection methods, including search 
strategy and keywords used for identifying references from online 
bibliographic databases. Discuss the quality of evidence. 
 When writing: clarify the evidence you used for key statements and the 
strength of the evidence. Do not present statements or opinions without such 
evidence, or if you have to, say that there is little or no evidence and that this 
is opinion. Avoid specialist jargon and abbreviations, and provide advice 
specific to southern Africa. 
 Personal details: Please supply your qualifications, position and affiliations 
and MP number (used for CPD points); address, telephone number and fax 
number, and your e-mail address; and a short personal profile (50 words) and 
a few words about your current fields of interest. 
  
Correspondence (Letters to the Editor) 
Guideline word limit: 500 words 
  
Letters to the editor should relate either to a paper or article published by the SAMJ 
or to a topical issue of particular relevance to the journal’s readership 
  
 May include only one illustration or table 
 Must include a correspondence address. 
  
Book reviews 
Guideline word limit: 400 words 
Should be about 400 words and must be accompanied by the publication details of 




Guideline word limit: 400 words 
Should be offered within the first year of the practitioner’s death, and may be 
accompanied by a photograph. 
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Guidelines  
Guidelines should always be discussed with the Editor prior to submission. 
Because of the intensive review process required to ensure Guidelines are 
independent, evidence-based and free from commercial bias, they are usually 
published as a supplement to the SAMJ, the costs of which must be covered by 
sponsorship, advertising or payment by the guideline authors/association. We will 
provide a quote based on the expected length of the guideline and whether it is to 
appear online only, or in print, which must be accepted by the body putting the 
guidelines together before submitting the work to the SAMJ. 
The Editor reserves the right to determine the scheduling of supplements. 
Understandably, a delay in publication must be anticipated dependent upon editorial 
workflow. 
All guidelines should be structured according to Agree II. 
Please access this website before putting the guidelines together, download the Agree 
11 instrument and use this to put the guidelines together. 
All submitted guidelines will be sent to the local Agree II appraisal committee for 
review and must be endorsed by an appropriate body prior to consideration and all 
conflicts of interest expressed. 
A structured abstract not exceeding 400 words (recommended sub-
headings: Background, Recommendations, Conclusion) is required. Sections and sub-
sections must be numbered consecutively (e.g. 1. Introduction; 1.1 Definitions; 
2.etc.) and summarised in a Table of Contents.
Illustrations/photos/scans 
 If illustrations submitted have been published elsewhere, the author(s) should
provide consent to republication obtained from the copyright holder.
 Figures must be numbered in Arabic numerals and referred to in the text e.g.
'(Fig. 1)'.
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 Each figure must have a caption/legend: Fig. 1. Description (any
abbreviations in full).
 All images must be of high enough resolution/quality for print.
 All illustrations (graphs, diagrams, charts, etc.) must be in PDF form.
 Ensure all graph axes are labelled appropriately, with a heading/description
and units (as necessary) indicated. Do not include decimal places if not
necessary e.g. 0; 1.0; 2.0; 3.0; 4.0 etc.
 Scans/photos showing a specific feature e.g. Intermediate magnification
micrograph of a low malignant potential (LMP) mucinous ovarian tumour.
(H&E stain). –include an arrow to show the tumour.
 Each image must be attached individually as a 'supplementary file' upon
submission (not solely embedded in the accompanying manuscript) and
named Fig. 1, Fig. 2, etc.
Tables 
 Tables should be constructed carefully and simply for intelligible data
representation. Unnecessarily complicated tables are strongly discouraged.
 Embed/include each table in the manuscript Word file - do not provide
separately as supplementary files.
 Number each table in Arabic numerals (Table 1, Table 2, etc.) and refer to
consecutively in the text.
 Tables must be cell-based (i.e. not constructed with text boxes or tabs) and
editable.
 Ensure each table has a concise title and column headings, and include units
where necessary.
 Footnotes must be indicated with consecutive use of the following symbols: *
† ‡ § ¶ || then ** †† ‡‡ etc.
Do not: Use [Enter] within a row to make ‘new rows’: 
Rather: 
Each row of data must have its own proper row: 
Do not: use separate columns for n and %: 
Rather: 
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Combine into one column, n (%): 
Do not: have overlapping categories, e.g.: 
Rather: 
Use <> symbols or numbers that don’t overlap: 
References 
NB: Only complete, correctly formatted reference lists in Vancouver style will be 
accepted. Reference lists must be generated manually and not with the use of 
reference manager software. Endnotes must not be used. 
 Authors must verify references from original sources.
 Citations should be inserted in the text as superscript numbers between square





 All references should be listed at the end of the article in numerical order of
appearance in the Vancouver style (not alphabetical order).
 Approved abbreviations of journal titles must be used; see the List of
Journals in Index Medicus.
 Names and initials of all authors should be given; if there are more than six
authors, the first three names should be given followed by et al.
 Volume and issue numbers should be given.
 First and last page, in full, should be given e.g.: 1215-1217 not 1215-17.
 Wherever possible, references must be accompanied by a digital object
identifier (DOI) link). Authors are encouraged to use the DOI lookup service
offered by CrossRef:
o On the Crossref homepage, paste the article title into the ‘Metadata
search’ box.
o Look for the correct, matching article in the list of results.
o Click Actions > Cite
o Alongside 'url =' copy the URL between { }.
o Provide as follows, e.g.: http://dx.doi.org/10.7196/07294.937.98x
Some examples: 
 Journal references: Price NC, Jacobs NN, Roberts DA, et al. Importance of




 Book references: Jeffcoate N. Principles of Gynaecology. 4th ed. London: 
Butterworth, 1975:96-101. 
 Chapter/section in a book: Weinstein L, Swartz MN. Pathogenic Properties 
of Invading Microorganisms. In: Sodeman WA, Sodeman WA, eds. 
Pathologic Physiology: Mechanisms of Disease. Philadelphia: WB Saunders, 
1974:457-472. 
 Internet references: World Health Organization. The World Health Report 
2002 - Reducing Risks, Promoting Healthy Life. Geneva: WHO, 2002. 
http://www.who.int/whr/2002 (accessed 16 January 2010). 
 Legal references 
•              Government Gazettes: 
National Department of Health, South Africa. National Policy for Health Act, 1990 
(Act No. 116 of 1990). Free primary health care services. Government Gazette No. 
17507:1514. 1996. 
In this example, 17507 is the Gazette Number. This is followed by :1514 - this is the 
notice number in this Gazette. 
•              Provincial Gazettes: 
Gauteng Province, South Africa; Department of Agriculture, Conservation, 
Environment and Land Affairs. Publication of the Gauteng health care waste 
management draft regulations. Gauteng Provincial Gazette No. 373:3003, 2003. 
•              Acts: 
South Africa. National Health Act No. 61 of 2003. 
•              Regulations to an Act: 
South Africa. National Health Act of 2003. Regulations: Rendering of clinical 
forensic medicine services. Government Gazette No. 35099, 2012. (Published under 
Government Notice R176). 
•              Bills: 
South Africa. Traditional Health Practitioners Bill, No. B66B-2003, 2006. 
•              Green/white papers: 
South Africa. Department of Health Green Paper: National Health Insurance in South 
Africa. 2011. 
•              Case law: 
Rex v Jopp and Another 1949 (4) SA 11 (N) 
Rex v Jopp and Another:  Name of the parties concerned 
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1949: Date of decision (or when the case was heard) 
(4): Volume number 
SA: SA Law Reports 
11: Page or section number 
(N): In this case Natal - where the case was heard. Similarly, (C) woud indicate 
Cape, (G) Gauteng, and so on. 
NOTE: no . after the v 
 Other references (e.g. reports) should follow the same format: Author(s). 
Title. Publisher place: Publisher name, year; pages. 
 Cited manuscripts that have been accepted but not yet published can be 
included as references followed by '(in press)'. 
 Unpublished observations and personal communications in the text must not 
appear in the reference list. The full name of the source person must be 




From submission to acceptance 
Submission and peer-review 
To submit an article: 
 Please ensure that you have prepared your manuscript in line with the SAMJ 
requirements. 
 All submissions should be submitted via Editorial Manager 
 The following are required for your submission to be complete: 
o Anonymous manuscript (unless otherwise stated) 
o Author Agreement form 
o Manuscript 
o Any supplementary files: figures, datasets, patient consent form, 
permissions for published images, etc. 
 Once the submission has been successfully processed on Editorial Manager, it 
will undergo a technical check by the Editorial Office before it will be 
assigned to an editor who will handle the review process. If the author 
guidelines have not been appropriately followed, the manuscript may be sent 
back to the author for correcting. 
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Peer-review process 
Article Processing Charges 
There is currently no article-processing charge (APC), also known as page fees, for 
the publication of manuscripts. This is subject to change however. 
As no pay-to-view fees are charged for access to SAMJ articles, publication costs – 
including those of peer review management, journal production and online/print 
publication – will in future need to be absorbed by the introduction of APC to 
authors, institutions or funders of accepted articles. Waiver requests may be 
considered on a case-by-case basis and at the sole discretion of HMPG. Further 
information will be provided in due course. 
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Please refer to the section on ‘Sponsored Supplements’ [hyperlink to relevant text 
above] regarding the publication of supplements, where a charge is currently 
applicable. Queries can be directed to Dianes@hmpg.co.za or Claudian@hmpg.co.za 
  
Production process 
The following process should usually take between 4 - 6 weeks: 
1. An accepted manuscript is passed to a Managing Editor to assign to a 
copyeditor (CE). 
2. The CE copyedits in Word, working on house style, format, 
spelling/grammar/punctuation, sense and consistency, and preparation for 
typesetting. 
3. If the CE has an author queries, he/she will contact the corresponding author 
and send them the copyedited Word doc, asking them to solve the queries by 
means of track changes or comment boxes. 
4. The authors are typically asked to respond within 1-3 days. Any 
comments/changes must be clearly indicated e.g. by means of track changes. 
Do not work in the original manuscript - work in the copyedited file sent to 
you and make your changes clear. 
5. The CE will finalise the article and then it will be typeset. 
6. Once typeset, the CE will send a PDF of the file to the authors to complete 
their final check, while simultaneously sending to the 2nd-eye proofreader. 
7. The authors are typically asked to complete their final check and sign-off 
within 1-2 days. No major additional changes can be accommodated at this 
point. 
8. The CE implements the authors’ and proofreader’s mark-ups, finalises the 
file, and prepares it for the upcoming issue. 
  
 
Changing contact details or authorship 
Please notify the Editorial Department of any contact detail changes, including email, 
to facilitate communication. 
  
 Publication  
Online v. print  
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The SAMJ is an online journal. The online version of the journal is the one that has 
the widest circulation, is indexed by bibliographic databases including PubMed and 
SciELO, and is accessible in academic libraries. A printed edition , containing 
material selected by the Editor is also published each month and distributed to the 




 The full text of all accepted articles is published in full online, open access, 
within 4 - 6 weeks of acceptance. 
 Citation information of each article is based on its online publication. 
 You may want to make use of the advantages of online publication e.g. 
specify web links to other sources, images, data or even a short video. 
  
Print 
 Not all articles will be selected for print. 
 An article may be selected for print in a different month from that in which it 
was published online. 
 Research articles will appear in abstract form only, if selected for a print 
edition. 
  
Errata and retractions  
Errata 
Should you become aware of an error or inaccuracy in yours or someone else’s 
contribution after it has been published, please inform us as soon as possible via an 
email to publishing@hmpg.co.za,including the following details: 
 Journal, volume and issue in which published 
 Article title and authors 
 Description of error and details of where it appears in the published article 
 Full detail of proposed correction and rationale 
  
We will investigate the issue and provide feedback. If appropriate, we will correct 
the web version immediately, and will publish anerratum  in the next issue. The 
correction will be indexed, as PubMed has a function for linking errata back to the 
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original article. All investigations will be conducted in accordance with guidelines 
provided by the Committee on Publication Ethics (COPE). 
  
Retractions 
Retraction of an article is the prerogative of either the original authors or the editorial 
team of HMPG. Should you wish to withdraw your article before publication, we 
need a signed statement from all the authors. 
  
Should you wish to retract your published article, all authors have to agree in writing 
before publication of the retraction. 
Send an email to publishing@hmpg.co.za, including the following details: 
 Journal, volume and issue to which article was submitted/in which article was 
published 
 Article title and authors 
 Description of reason for withdrawal/retraction. 
  
We will make a decision on a case-by-case basis upon review by the editorial 
committee in line with international best practices. Comprehensive feedback will be 
communicated with the authors with regard to the process. In case where there is any 
suspected fraud or professional misconduct, we will follow due process as 
recommended by the Committee on Publication Ethics (COPE), and in liaison with 
any relevant institutions. 
  




The SAMJ has an impact factor of 1.712. 
Published articles are covered by the following major indexing services. As such 
articles published in the SAMJ are immediately available to all users of these 
databases, guaranteed a global and African audience: 
 Index Medicus (Medline/PubMed) 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 ExcerptaMedica (EMBASE) 
 Biological Abstracts (BIOSIS) 
 Science Citation Index (SciSearch) 







Sponsored supplements  
Contact claudian@hmpg.co.za for information on submitting ad hoc/commissioned 
supplements, including guidelines, conference/congress abstracts, Festschrifts, etc. 
  
  
Submission Preparation Checklist 
As part of the submission process, authors are required to check off their 
submission's compliance with all of the following items, and submissions may be 
returned to authors that do not adhere to these guidelines. 
1. Named authors consent to publication and meet the requirements of 
authorship as set out by the journal. 
2. The submission has not been previously published, nor is it before another 
journal for consideration. 
3. The text complies with the stylistic and bibliographic requirements in Author 
Guidelines. 
4. The manuscript is in Microsoft Word or RTF document format. The text is 
single-spaced, in 12-point Times New Roman font, and contains no 
unnecessary formatting. 
5. Illustrations/figures are high resolution/quality (not compressed) and in an 
acceptable format (preferably TIFF or PNG). These must be submitted 
individually as 'supplementary files' (not solely embedded in the manuscript). 
6. For illustrations/figures or tables that have been published elsewhere, the 
author has obtained written consent to republication from the copyright 
holder. 
7. Where possible, references are accompanied by a digital object identifier 
(DOI) and PubMed ID (PMID)/PubMed Central ID (PMCID). 
8. An abstract has been included where applicable. 
9. The research was approved by a Research Ethics Committee (if applicable) 




Copyright of published material remains in the Authors’ name. This allows authors 
to use their work for their own non-commercial purposes without seeking permission 
from the Publisher, subject to properly acknowledging the Journal as the original 
place of publication. 
 Authors are free to copy, print and distribute their articles, in full or in part, for 
teaching activities, and to deposit or include their work in their own personal or 
institutional database or on-line website. Authors are requested to inform the 
Journal/Publishers of their desire/intention to include their work in a thesis or 
dissertation or to republish their work in any derivative form (but not for commercial 
use).  
 Material submitted for publication in the SAMJ is accepted provided it has not been 
published or submitted for publication elsewhere. Please inform the editorial team if 
the main findings of your paper have been presented at a conference and published in 
abstract form, to avoid copyright infringement. 
Privacy Statement 
The SAMJ is committed to protecting the privacy of the users of this journal website. 
The names, personal particulars and email addresses entered in this website will be 
used only for the stated purposes of this journal and will not be made available to 
third parties without the user’s permission or due process. Users consent to receive 
communication from the SAMJ for the stated purposes of the journal. Queries with 
regard to privacy may be directed to publishing@hmpg.co.za. 
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